Based on research at University of Notre Dame, Happe Spine is working on implants for interbody spinal fusion.

Happe Spine, a US-based implant technology producer based on research at University of Notre Dame, has raised an undisclosed sum from medical device-focused venture capital funds Cultivate(MD) Fund I and Cultivate(MD) Fund II.
Founded in July 2018, Happe Spine is commercialising a material to construct partial and fully porous, bioactive Peek implants that can be used for interbody spinal fusion.
The technology is based on research by Ryan Roeder in Notre Dame’s Department of Aerospace and Mechanical Engineering.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email
Linked in